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Abstract 
Introduction: Magnetic stimulation (MS) has the ability to induce muscle twitch 
and has long been proposed as a therapeutic modality for skeletal muscle diseases. 
However, the molecular mechanisms underlying its means of action have not been 
defined. 
Methods: Muscle regeneration after trauma was studied in a standard muscle 
injury mouse model. The influence of MS on the formation of motor-units, post-trauma 
muscle/nerve regeneration, and vascularization was investigated. 
Results: We found that MS does not cause systemic or muscle damage but 
improves muscle regeneration by significantly minimizing the presence of inflammatory 
infiltrate and formation of scars after trauma. It avoids post-trauma muscle atrophy, 
induces muscle hypertrophy, and increases the metabolism and turnover of muscle. It 
triples the expression of muscle markers and significantly improves muscle functional 
recovery after trauma. 
Discussion: Our results indicate that MS supports muscle and nerve regeneration 
by activating muscle-nerve cross-talk and inducing the maturation of NMJs. 
 
Keywords: Magnetic Stimulation Therapy, Nerve Regeneration, Rehabilitation 
Outcome, Muscle Contraction, Neuromuscular Junction 
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Introduction 
Magnetic stimulation (MS) was originally developed to stimulate central and 
peripheral nerves 1,2. More recently it has been proposed to promote neuromodulation 
and exercise training of deficient skeletal muscle 3,4. In humans, a magnetic coil 
wrapped around the quadriceps has been demonstrated to induce effortless muscle 
fatigue and training 4,5. A similar device for exercising the pelvic floor was designed in 
which magnetic pulses converged into a coil placed inside a chair seat 6. Magnetic 
stimulation has been used to treat urinary incontinence in women 7,8. Although 
promising preliminary clinical reports have been published 9,10, contradictory clinical 
studies with opposing outcomes using central 11,12 and peripheral MS 13 treatments 
urged the necessity for investigations demonstrating if and how MS could support the 
cellular machinery of muscle and/or nerves to promote muscle training 8. 
Nerve repair and prevention of post-traumatic muscle atrophy represent a major 
challenge in medical care. After trauma, an initial cleanup of damaged structures is 
necessary before natural reconstruction can take place. Schwann cells are the main cells 
responsible for removing damaged myelin, while macrophage infiltration is necessary 
for breakdown of damaged fragments of cells and fibers 14. Meanwhile, in the midst of 
the inflammatory reaction, muscle satellite cells are activated for muscle reconstruction. 
During this process, they fuse and build new myofibers with central nuclei, allowing 
muscle regeneration to occur within weeks 15. The newly formed myofibers require 
rapid functional innervation and mature neuromuscular junctions (NMJs) to complete 
their differentiation process and recover strength 16. Exercise is known to improve posttraumatic 
peripheral nerve lesions and improve function. MS can produce stimuli 
equivalent to endurance exercise in humans 4, but the mechanisms by which this occurs, 
as well as its impact on post-traumatic muscle reconstruction, remain poorly 
understood. 
In this study, a mouse muscle crush injury model was used to investigate the 
mode of action of MS on muscle tissue stimulation and post-trauma regeneration. The 
formation of motor units by MS was evaluated by assessing the clustering of 
acetylcholine receptors (AChRs) and known muscular metabolic adaptations caused by 
muscle contraction. Here, the influence of MS on post-trauma muscle/nerve 
regeneration and vascularization is investigated in detail, and its overall systemic impact 
is discussed. 
 
  
5 
Materials and Methods 
 
Ethical and animal experimental approval 
The animal experiments described in this study were analyzed carefully and approved 
by the Swiss veterinary inspection office of the canton of Zurich. The Swiss guidelines 
on animal welfare were followed rigorously. To assure minimum discomfort for the 
animals, a single intervention with crush injury and intramuscular injection of cells was 
performed, followed by muscle training under anesthesia. 
 
Muscle injury and magnetic stimulation in vivo 
Upon ethical and animal experimental approval 48 C57 mice (3-month-old 
females) received an upper-leg lateral incision from the lateral knee to the greater 
trochanter while under 5% isoflurane anesthesia using aseptic conditions, including 
shaved skin and betadine asepsis 17. A coronal plane was opened beneath the 
quadriceps, separating the muscle from the femur. The lower jaw of an artery forceps 18 
was inserted gently below the quadriceps. The crush injury was performed by closing 
the forceps to their first stage for 5 seconds, which produced a reproducible transverse 
injury of about 4mm. The forceps was gently removed, and the wound was closed. 
The animals were allowed free cage activity and free access to food and water. 
The animals received Carprofen (5 mg/kg/KGW, SC) prior to muscle injury, every 12 h 
thereafter, and at any sign of distress. After 5 days, the animals were divided randomly 
into 2 groups. Twenty mice received 3 sessions of 20 minutes MS under anesthesia 
(2.00 mg/30 g Ketamine and 0.06 mg/30 g Azepromazine) every second day delivered 
by the Biocon-2000W™ (Mcube Technology Co Ltd, Korea). The Biocon 2000W has a 
CE certification for clinical use (CE 120) and is sold in Europe and Asia. The 
manufacturer specifies a maximal electric power consumption of 2.5 kVA with a 
maximal discharge voltage of 1800V and a maximal two-phase discharge current of 
2200A at the level of the coil. The thighs of the animals were placed at the center of the 
coil, and each MS session was performed as described previously 6 (10 min/10Hz and 
10min/50 Hz, each pulse consisting of 3 s stimulation, 6 s rest). The other 20 mice with 
crush injuries served as controls. In order to rule out the effect of the anesthesia on 
muscle regeneration, control animals underwent anesthesia but received no MS. To 
assess the effect of MS in the absence of trauma, the remaining 8 mice received no 
muscle injury, and half of them were submitted to MS. Euthanasia was performed using 
CO2 followed by exsanguination. 
 
Immunohistochemistry 
The tissues were harvested 5 days after MS therapy to evaluate muscle 
regeneration, muscle atrophy, myofiber typing, and NMJ formation, as previously 
described 19. Briefly, the quadriceps muscle was removed, minced, and incubated in 
0.2% collagenase (60 min, 37 °C). Single muscle fibers were liberated by shearing 
using heat-polished Pasteur pipettes, washed in PBS and fixed (4% paraformaldehyde, 
10 min). Then, they were incubated in 0.3 M glycine (20 min), stained with α-BTX 
(1:20, Invitrogen) and DAPI (1:100, Sigma) for 1 hour, washed twice in PBS, 
transferred to a glass slide in DABCO (Sigma), and analyzed by fluorescence 
microscopy. At a 63× magnification, 20 fields were chosen randomly, and the number 
of NMJs was counted. The relative number of AChR clusters per muscle fiber (50 
muscle fibers per group) was analyzed. 
 
For histological analyses, the quadriceps muscles were dissected, embedded in 
OCT, and 10-μm frozen sections were prepared and air dried. Hematoxylin/eosin 
staining was carried out as described previously to assess the width of the scar and 
infiltration of inflammatory cells 20. Lymphocytes, neutrophils, and macrophages were 
not differentiated in this analysis. The tissues were fixed (100% methanol, -20 C), 
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permeabilized (0.5% Triton X-100, 7 min), and blocked (1% BSA, 0.1% Triton X-100 
in PBS, RT, 30 min). The concentrations of the antibodies used for immunolabeling 
were as follows: anti-Desmin (1:100, BD Biosciences), anti-myosin-heavy-chain (1:2, 
DSHB, Yowa), anti-myosin-heavy-chain-slow-twitch (1:5, DSHB, Yowa), anti-myosinheavy- 
fast-twitch (1:2, DSHB, Yowa), alpha-bungarotoxin (1:20, Invitrogen), antineurofilament68 
(1:300, Sigma), anti-von-Willebrand-factor (1:50, Abcam), and antismoothelin 
(1:100, Santa Cruz). The secondary antibodies were Alexa Fluor 488 antimouse- 
IgG (1:100, Brunschwig), FITC-anti-mouse-IgM (1:100, Sigma), Cy3-antimouse- 
IgG (1:1000, Sigma), Cy3-anti-rabbit-IgG (1:100, Sigma), FITC-anti-Sheep IgG 
(1:100, Abcam), and DAPI (Sigma). The images were acquired at exposures that were 
based on unstained controls and were taken with a confocal microscope (Leica SP5, 
Germany). 
 
Histomorphometrical measurements 
Muscle regeneration was evaluated by counting fibers with centrally located 
nuclei in 20 randomly chosen sections in a blinded fashion. This value was normalized 
to the total number of muscle fibers per field, which was defined as the regeneration 
ratio 21. Inflammatory infiltration was determined by the distance from the border of the 
injury that the inflammatory cells had migrated. The percentage of slow-twitch and fast- 
twitch fibers was determined by the immunostaining of type I fibers (FITC stained) and 
type II fibers (Cy3 stained). Muscle atrophy was assessed by measuring the crosssectional 
areas of the muscle fibers 22. Native and non-stimulated quadriceps muscles 
were used as controls for histology. The entire quadriceps muscle cross-section was 
analyzed (n=20, 20x HPF), with care taken to ensure comparable cross-section locations 
within and at the border of the induced muscle injury. Image J software (NIH, Bethesda, 
MD) for microscopy was used for measurements, and all data are expressed as the 
mean/SD. 
 
Serum creatinine, creatine kinase, bilirubin, myoglobin, and haptoglobin measurements 
To evaluate possible systemic effects of MS, blood was collected in heparincoated 
collection tubes (BD, Biosciences), and serum was isolated by centrifugation. 
Serum creatinine, creatine kinase, bilirubin, myoglobin, and haptoglobin activity were 
then determined with specific assays kits according to the manufacturer’s protocol 
(Diagnostic Chemicals Limited). 
 
Western blotting 
The samples of the crushed zone were carefully dissected, and western blot 
(WB) was performed as previously described 20. In summary, the tissues were 
pulverized in liquid nitrogen with a mortar and pestle, washed with PBS/protease 
inhibitor cocktail (P8340, Sigma), and lysed. The protein lysates were measured using 
the PierceR BCA Protein Assay Kit (Thermo Scientific), loaded on 12% Bio-Rad gels 
(30 μg), transferred onto PVDF membranes (Immobilon-P; Millipore, Bedford, MA), 
blocked 1 h in 5% non-fat dry milk, and incubated overnight at 4 °C with the primary 
antibodies. The primary antibodies were mouse anti-Desmin (1:500, BD Biosciences), 
mouse anti-myosin-heavy-chain (1:50, DSHB, Yowa), mouse anti-myosin-heavy-chain 
I (1:25, DSHB, Yowa), mouse anti-myosin-heavy-chain II (1:25, DSHB, Yowa), mouse 
PGP9.5-Neuronal Marker (1:2000, Abcam), anti-neurofilament 68 (1:1000, Sigma), 
rabbit anti-Agrin (1:200, Santa Cruz), and monoclonal anti-GAPDH (1:2000, Sigma). 
The membranes were washed in TBS/0.1% Tween-20 (30 min) and incubated for 1 h 
with the appropriate HRP-conjugated secondary antibody (Amersham, Dubendorf, 
Switzerland) in TBS/0.1% Tween-20/5% non-fat dry milk. The membranes were 
developed using the ECL technique (ECL-Kit, Amersham, Freiburg, Germany). The 
protein amounts were normalized to GAPDH. The quantification of each protein was 
performed using Image J software (NIH, Bethesda, MD). 
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Myography 
After careful dissection, muscle strips were kept under tension with constant 
oxygenation (95% O2 and 5% CO2) in Krebs solution at room temperature. Muscle 
strips were fastened with vicryl into the myograph-chambers (DMT, Denmark) and 
allowed to equilibrate for 20 min under 20 mN tension at 37 oC. Every 5 minutes, the 
tension was adjusted, and the Krebs solution was replaced. Single 80 V/80 Hz twitch 
stimulations were used to determine the optimum length (L0) of each tissue, and the 
maximum tension during tetanic contractions was registered. All data were collected 
using a LabChart v7.0 (ADinstruments, Spechbach, Germany) and expressed as the 
mean/SD. 
 
Statistics 
All of the data are expressed as averages with their corresponding standard 
deviations. For statistical analysis, SPSS v11 (SPSS Inc., Chicago, IL) was used, and 
the graphics were drawn with GraphPad Prism v5.04 (GraphPad Software, Inc.). All 
data were analyzed by independent samples t-tests or one-way ANOVA with 
Bonferroni post hoc analysis. P<0.05 was considered significant. 
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Results 
 
Magnetic stimulation causes no systemic or muscle damage but improves muscle 
regeneration 
After 5 days of MS treatment, muscle and blood samples were collected and 
compared to non-stimulated controls (Figure 1). To evaluate the systemic effects of MS 
in vivo, the circulating blood concentrations of creatinine, creatine kinase, bilirubin, 
myoglobin, and haptoglobin were measured. During stimulation, MS triggered clearly 
visible muscle contractions. The levels of haptoglobin, bilirubin, and creatinine were 
within the normal range, indicating the absence of hemolysis and hepatic or kidney 
damage in both groups. Circulating myoglobin levels (Figure 1C) were similar and 
slightly elevated in both stimulated and control animals (24.6 }2.3 μg/l and 25.2 }1.3 
μg/l, respectively, P=0.313). Conversely, the levels of creatine kinase increased 5-fold 
in the samples from the stimulated group (control 193.5  }90.36 U/l and 933.3 }10.54 U/l, 
respectively, P<0.001). This finding, associated with the comparable myoglobin levels, 
indicates the presence of exercise without significant additional muscle damage after 
MS (Figure 1D). 
The histomorphometrical analysis of the muscle injury site (Figures 1E, 1F, and 
1G) demonstrated that the MS-treated group showed a reduction in post-traumatic scar 
formation (214.2 }57.8 μm) equal to one-third of the control values (686.3 }71.8 μm, 
P<0.001). The samples from the MS group also demonstrated reduced infiltration of 
inflammatory cells (347.4 }18.9 μm), while samples from the control group displayed 
inflammatory cells at distances of up to 637.5 }64.02 μm of the scar interface (P<0.001). 
In addition, we assessed the presence of neovascularization by comparing the double- 
staining of von Willebrand factor (vWf) and smoothelin in both groups (Figures 1I and 
1J). As expected, the injury site of the non-stimulated samples had increased 
vascularization (vWf 162 }19.2%, P=0.003 and smoothelin 190.8 }24.4%, P=0.001). 
However, in the MS-treated samples, the number of vessels within the scar was reduced 
to values similar to that of unscathed control muscle 5 days after injury (vWf 96.3 }6.3% 
and smoothelin 97.9 }25.0%). 
 
Magnetic stimulation reduces post-trauma muscle atrophy and induces the hypertrophy 
of unscathed tissue 
Muscle fiber cross-section measurements were performed within the injury 
region and at the interface with normal muscle (Figure 2). We found that the myofibers 
within the injury regions without MS had reduced cross-sections of 38.56%  }1.64 
(P<0.001, Figures 2A, 2B, and 2C) of an intact quadriceps myofiber. In contrast, MSstimulated 
muscle did not undergo atrophy, showing fiber cross-section values similar 
to or larger than unharmed non-stimulated controls (114.4% }5.2, P<0.05). Furthermore, 
the muscle regenerative process, demonstrated by the presence of myotubes with central 
nuclei, was significantly increased (P<0.001) by MS (Figure 2D). A total of 80.7%  }7.0 
of the muscle fibers in the injury site of MS-treated samples displayed central nuclei, 
whereas only 41.5% }8.1 of myofibers in untreated crushed muscle fibers were 
regenerating myofibers. 
Additional analyses of tissue at the injury interface demonstrated that the muscle 
adjacent to the trauma location became atrophic in non-stimulated samples. Specifically, 
the muscle fiber cross-sections were reduced to 69.9 }8.5% of control (P=0.002, Figures 
2E, 2F, and 2G). MS treatment was sufficient to prevent this process, not only by 
inducing hypertrophy (134.5 }6.5%, P<0.001) but also by again increasing the 
regenerative process (Figures 2G and 2H). At the interface with normal muscle, we 
found that 50.0 }7.2% of the MS-treated myofibers displayed central nuclei, while only 
20.1 }2.0% of the untreated sample myofibers were regenerating (Figure 2H). 
 
Magnetic stimulation induced a shift of muscle fiber type to slow-twitch and improved 
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muscle contractile force 
Analyses of immunostained muscle slices and semi-quantitative protein 
measurements were performed to estimate the impact of MS on muscle protein 
expression and fiber typing. Muscle-specific proteins, such as myosin heavy chain 
(MyH), tended to increase (control 0.43  }0.06, stimulated 0.74 }0.26, P=0.056), and 
desmin (Figure 3A) doubled its expression after 5 days of magnetic stimulation (control 
0.78  }0.25, stimulated 1.6 }0.26, P=0.021). Our western blot (WB) results indicated a 3- 
fold increase in MyH1 (control 0.42  }0.11 and stimulated 1.46 }0.31, P<0.001, Figure 
3B), whereas no significant increase in MyH2 expression (control 0.11 }0.10 and 
stimulated 0.19 }0.07, p=0.09, Figure 3C) could be detected after stimulation. 
Immunostaining with MyH1/MyH2 confirmed the WB data, demonstrating that MS 
boosted MyH type 1 expression (Figures 3D and 3E) when compared to non-stimulated 
controls (128.3 }24.4%, P<0.05) and native control quadriceps (278.8 }35.6%, P<0.001, 
Figure 3F). When compared to native control muscle tissue, the consequent decrease in 
MyH type 2 (control 103.4 }13.4%, P=0.2643 and stimulated 68.6 }9.3%, P<0.001) after 
MS (Figure 3G) again underlined the shift to slow-twitch fibers. 
The myography of native control and damaged muscle tissue demonstrated that 
MS improved the contractile force of normal muscle and supported the recovery of 
muscle contractile response to electrical stimulation after damage (Figure 4). In the 
absence of trauma, muscle tetanic contraction forces significantly increased after 5 days 
of training with MS, as demonstrated in 2 electrical stimulation settings: 40 V/40 Hz 
(control 3.34  }0.7 g and stimulated 5.7 }1.2 g, P<0.05) and 80 V/80 Hz (control 8.0 }1.3 
g and stimulated 13.7 }2.7 g, P<0.05, Figure 4A). As demonstrated in Figure 4B, crush 
injury was sufficient to reduce muscle strength to approximately one-half of native 
controls (crush injury 4.6  }1.0 g and native controls 9.4 } 3.2 g). Likewise, a significant 
recovery of muscle strength could be observed following crush injury after 5 days of 
treatment with MS using 40 V/40 Hz (control 1.03  }0.27 g and stimulated 2.5 }0.2 g, 
P<0.001) and 80 V/80 Hz (control 2.6  }0.9 g and stimulated 4.7 }0.5 g, P<0.05, Figure 
4C). This recovery was sufficient to recover muscle strength values comparable to 
uninjured muscle (control 3.3  }0.7 g and stimulated 2.5 }0.2 g, P=0.216, Figure 4D), 
suggesting that MS may be useful for muscle rehabilitation after trauma. 
 
Magnetic stimulation promotes nerve ingrowth and acetylcholine receptor clustering 
after injury 
To verify the influence of MS in recovery of innervation after injury, we 
analyzed the regenerating muscle tissue by evaluating muscle/nerve components and the 
formation of NMJs. We found evidence of improved cross-talk between muscles and 
nerves (Figure 5A), thus promoting the maturation of neuromuscular junctions (NMJs) 
after MS treatment. Agrin levels were significantly higher in MS-treated samples 
(control 0.70  }0.17 and treated 1.06 }0.13, P=0.046). Likewise, expression of 
neurofilament protein NF68 (control 0.71  }0.10 and treated 1.26 }0.16, P=0.026) and 
PGP 9.5 (control 0.47  }0.12 and treated 0.78 }0.15, P=0.003) were upregulated (Figures 
5B and 5C). Additionally, the coefficient of the stimulated samples was not only higher 
than that of non-stimulated samples (control 40.7  }4.0 and stimulated 143.9 }21.7, 
P<0.001) but also surpassed (P=0.036) even the coefficient found in a normal 
quadriceps muscle (Figures 5D, 5E, and 5F). Moreover, the total number of AChR 
clusters per high-power field (HPF) was clearly higher in MS-treated samples (control 
3.9  }0.6 and treated 7.1 }1.1, P=0.021, Figures 5G, 5H, and 5I). Finally, AChR 
displayed better organization and distribution in the MS-treated muscle fibers (control 
0.07  }0.04 and treated 0.61 }0.09, P<0.001), with up to 8-fold increases in the total 
number of clusters per muscle fiber (Figures 5J, 5K, and 5L). 
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Discussion 
Magnetic fields can be used to trigger muscle contraction. However, clinical 
studies remain inconclusive, and no molecular mechanism underlying this action has 
been described. Using an in vivo model of muscle injury, we studied the impact of MS 
treatment on post-traumatic muscle and nerve regeneration. We found that MS a) causes 
no systemic or muscle damage; b) improves muscle regeneration by reducing 
inflammatory infiltrate and avoiding post-trauma muscle atrophy; c) improves muscle 
contractile function by inducing myofiber hypertrophy; d) promotes acetylcholine 
receptor clustering and nerve ingrowth after injury; and in our setting, e) induces a 
muscle fiber type switch to slow-twitch. 
The major advantage that makes MS an interesting rehabilitation treatment 
modality is its capability to excite a specific target in a painless and non-invasive 
manner. In our mouse model, we found that only creatine kinase (CK) levels increased, 
which, in the absence of other rhabdomyolysis markers, indicates a muscle workout 
without significant tissue damage 23. After endurance exercise, CK is expected to 
increase at least 3-fold compared to resting conditions 24. Earlier studies have supported 
our findings by establishing that MS causes less damage to muscle than direct electrical 
stimulation, as indicated by only a limited rise of creatine metabolites 25. MS has also 
been used in patients with chronic illness, including chronic obstructive pulmonary 
disease (COPD) 4, multiple sclerosis, 26 and hypertension, 27 and even during pregnancy 
28 without complications. 
MS could play an important role in post-traumatic skeletal muscle regeneration. 
A previous report has suggested that MS might facilitate regeneration in skeletal muscle 
damage induced by mepivacaine 29. However, this anesthetic is known to produce 
muscle fiber lysis while sparing the vascular bed, nerve endings, and satellite cells 30 
and is therefore not a good model for the damage caused by trauma. In our experiments 
we excluded the effects of anesthesia on muscle regeneration by exposing all animals 
(treated or controls) to the same number of anesthesia sessions. We have demonstrated 
the post-trauma impact of MS treatment in promoting muscle regeneration, nerve 
ingrowth, and AChR clustering in a mouse model after muscle crush. MS decreased the 
inflammatory infiltrate, prevented myofiber atrophy, boosted muscle protein expression, 
and significantly increased the number of regenerating fibers. 
We observed that MS influences native muscle fibers adjacent to the site of 
injury, inducing phenotypic changes compatible with the effects of exercise. MS 
increased fiber cross-section and even supported new fiber formation within healthy 
regions of the muscle. We also found that repetitive muscle stimulation for 20 minutes 
every second day during muscle healing can significantly support regeneration. Recent 
studies have demonstrated that magnetic fields induce myoblast differentiation 31 and 
promote myofiber hypertrophy 32. The increased number of myofibers with central 
nuclei at the injury interface of MS-stimulated samples seems to play an important role 
in the overall regeneration process of the damaged tissue. This finding, together with the 
hypertrophic state of MS-treated muscles, would explain the decrease in size of the 
injury scar in stimulated samples. We speculate that MS has the potential to activate and 
induce differentiation of resident satellite cells in situ. This is important, because it 
indicates that MS acts not only at sites of injury but also in adjacent tissues, which could 
then synergistically improve regeneration and muscle rehabilitation after trauma. 
Early NMJ formation is marked by intensive cross-talk between muscle cells and 
nerve fibers that is mediated through Agrin secretion. Agrin is a heparan sulfate 
proteoglycan that activates muscle-specific kinase (MuSK) to cluster cholinergic 
receptors in the post-synaptic endplate 33. It also acts as an envoy between the nerves 
and muscles, initiating the cascade that promotes NMJ maturation and regulates 
synaptic function 34. Our results indicate that the increase in neuronal ingrowth detected 
in MS-treated tissues was also associated with an increase in Agrin. This finding went 
hand-in-hand with muscle differentiation and accumulation of AChR, which is known 
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to be indicate a functional NMJ 35. Finally, our results indicate that in the settings used, 
MS mimics the effects of exercise, which increases turnover and causes hypertrophy in 
skeletal muscle 36. Taken together, these findings indicate that MS induces neuronal 
ingrowth and myoblast differentiation by promoting muscle-nerve cross-talk and 
inducing the maturation of NMJs. 
With the settings used, MS distinctly influenced muscle fiber type-decision. We 
found that during the regeneration process in vivo, fibers formed under MS treatment 
tended to shift their fiber type to slow-twitch (MyH1). It has been described that during 
regeneration, newly formed myotubes tend to follow the intrinsic typing characteristics 
of the prior fibers 37. Although the quadriceps is mainly a fast-twitch type of muscle 38, 
we detected a 3-fold increase in type 1 (slow-twitch) fibers after MS treatment. 
These results propose that MS could be an efficient support to post-trauma 
rehabilitation after acute nerve and muscle damage. Astonishingly, these results were 
achieved in mice after as few as 3 sessions of 20 minutes of MS (10 min/10Hz followed 
by 10min/50 Hz). The device used in this study has been developed to treat stress 
urinary incontinence in humans and is designed to reach the human pelvic floor in the 
sitting position. We acknowledge that this is beyond what would be necessary to 
stimulate the lower legs of a small C57 mouse alone. This study cannot answer if a 
lower magnitude of stimulation would induce similar results. Further, systematic 
studies exploring the effects of MS on functional rehabilitation in chronically damaged 
skeletal muscle would complete our understanding of the mechanisms by which MS 
acts on muscle injury. 
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Abbreviations: 
α-BTX, α-bungarotoxin; 
AChRs, acetylcholine receptors; 
CK, creatine kinase; 
HPF, high-power-field; 
MS, magnetic stimulation; 
MuSK, muscle-specific kinase; 
MyH, myosin heavy chain; 
NMJ, neuromuscular junction; 
vWf, Willebrand factor; 
WB, western blot. 
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Figure Legends: 
 
Figure 1 – MS causes no systemic damage, accelerates the regeneration process, 
and reduces scar width and inflammatory infiltrates. (A, B) The degree of injury to 
the quadriceps was reduced after MS treatment. (C) The levels of systemic myoglobin 
after MS stimulation were comparable with normal parameters. (D) Conversely, the 
systemic values of creatine kinase increased up to 5-fold. Dashed lines indicate normal 
values. (E, F, G) Hematoxylin and eosin-stained sections demonstrated that the crush 
injury scar was significantly reduced after 5 days of MS treatment. (H) Simultaneously, 
the extension of the inflammatory infiltrate, as assessed by the presence of lymphocytes 
and macrophages on the interface of injury, was reduced to half. (I, J) Staining with 
smoothelin/Cy3 (red), von Willebrand factor/FITC (green) and DAPI (blue) 
demonstrated a lower density of new vessels at day 5 in the MS-treated samples. (K, L) 
While the control samples still displayed at least a 150% higher number of micro 
vessels when compared to intact quadriceps , MS-treated samples demonstrated values 
similar to native tissue. +MS indicates magnetic stimulation treatment, whereas -MS 
represents the non-stimulated controls (*P<0.05, **P<0.001). 
 
Figure 2 – MS reduces post-trauma muscle atrophy, boosts muscle turn-over, and 
induces hypertrophy of the injury interface. Muscle fiber cross-section 
measurements were performed in study animals after muscle crush with or without MS 
within the central zone of the injury and at the border. The values were then normalized 
with muscle fiber cross-section of the control unscathed muscle and expressed as 
percentage of it. The isolated effect of MS on the injury center (A-D) and on the 
interface (E-H) was analyzed. (A, B, C) In the center of the injury site, MS induced 
hypertrophy and doubled the cross-sectional diameter of the fibers. (D) This effect was 
associated with a remarkable increase in the regeneration ratio, as represented by 
muscle fibers with central nuclei. (E, F) Similarly, in the injury interface, the 
inflammatory infiltrate was reduced, and (G) the fiber cross-sections were again 
hypertrophic, with fiber cross-sections that were approximately 40% larger than in 
control and MS-untrained quadriceps. (H) The regeneration ratio, as assessed by the 
percentage of myofibers with central nuclei, was almost 3 times higher in stimulated 
samples. +MS indicates the presence of magnetic stimulation treatment, whereas -MS 
represents the unstimulated controls (**P<0.001) 
 
Figure 3 – MS induces a muscle type switch to slow-twitch fibers – After crush injury 
and MS treatment, the quadriceps was retrieved and analyzed by western blot or 
histology. We found that the expression of muscle proteins was increased after MS 
treatment. (A) Desmin nearly doubled its expression levels, and (B) a specific increase 
in MyH type 1 could be detected. (C) No significant difference in MyH type 2 was 
found by WB. (D, E, F) Staining was performed with anti-myosin-heavy-chain-slowtwitch/ 
FITC-anti-mouse-IgM (green), anti-myosin-heavy-chain-fast-twitch/Cy3-antimouse- 
IgG (red), and DAPI (blue). When compared with intact control quadriceps, no 
fiber type change was found in injured muscle without MS stimulation. (E) On the other 
hand, a shift to type 1 fibers was verified in MS-treated samples. (F) MyH type 1 
expression was up to 3-fold higher in MS-treated samples than in native muscle. (G) As 
expected, a relative decrease in MyH type 2 was detected. +MS indicates magnetic 
stimulation treatment, whereas -MS represents the unstimulated controls (*P<0.05, 
**P<0.001) 
 
Figure 4 – MS improves muscle contractile strength of native control muscle tissue 
and aids in the recovery of muscle contractile strength after trauma –After 5 days 
of magnetic stimulation, the muscles were retrieved and assessed. Organ bath of tibialis 
muscle strips was performed using 40-80V and 40-80Hz. (A) In native control muscle 
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tissue, MS increased the contractile strength to 150% of non-stimulated samples. (B) 
Representative organ bath contractions at 40 V/40 Hz. The induced muscle crush injury 
was sufficient to reduce muscle contractile strength to approximately one-half (dashed 
line) of that of control muscles (continuous line). (C) MS treatment after injury 
significantly promoted the recovery of lost muscle strength after trauma. +MS indicates 
magnetic stimulation treatment, whereas -MS represents the non-stimulated controls 
(*P<0.05, **P<0.001). 
 
Figure 5 – MS intensifies muscle-nerve cross-talk, increases nerve ingrowth, and 
promotes AChR clustering. Analyses of the nerve component within the injured 
muscle were performed by WB and immunostaining. (A) Agrin expression was 
increased, (B, C) along with specific neurofilament 68 (NF68) and the PGP9.5-neuronal 
marker. (D, E) Immunostaining confirmed the WB results, demonstrating an increased 
number of nerves in the tissues after MS. Staining was performed with neurofilament 
68/488-anti-mouse-IgG (green), α-BTX (red), and DAPI (blue). (F) Surprisingly, the 
amount of nerves detected after MS was approximately 50% higher compared to normal 
tissue. (G, H, I) NMJ staining of acetylcholine receptors (AChR) with α-bungarotoxin 
 (red) demonstrated that they were more clustered and had a significantly higher density 
after MS. (J, K) Analysis of single fibers isolated from the entire injury area after 
collagenase digestion demonstrated the total ratio of AChR cluster per muscle fiber. (L) 
The total number of clusters per fiber was 4-fold higher in MS-treated samples, 
demonstrating the positive effect of MS in reorganizing the neuromuscular junction 
after trauma. +MS indicates magnetic stimulation treatment, whereas -MS represents 
non-stimulated controls (*P<0.05, **P<0.001) 





